That certainly is a good question and I don't have
Post# of 155140
(Total Views: 627)
Posted On: 12/02/2020 12:42:47 PM
That certainly is a good question and I don't have an answer. My guess though is that if they wait for 100% enrollment at 42 days observation, and take a couple of weeks to gather, analyze, & state topline results, it could be late February.
If the next review at 75% is with 28 day data for patient 293, then I expect to hear something in early January at the earliest, keeping in mind that the data collection and analysis is occurring during the holidays. I have no idea if they will unblind then but think it would be much more likely they would if they already have 14-day data on the 100%.
I do not expect CYDY to tell us in advance about whether they will wait for 42-day data on the 100%. I'm inclined to believe that they will gather some of that data but not wait for it all since it isn't an official endpoint at this time.
If the next review at 75% is with 28 day data for patient 293, then I expect to hear something in early January at the earliest, keeping in mind that the data collection and analysis is occurring during the holidays. I have no idea if they will unblind then but think it would be much more likely they would if they already have 14-day data on the 100%.
I do not expect CYDY to tell us in advance about whether they will wait for 42-day data on the 100%. I'm inclined to believe that they will gather some of that data but not wait for it all since it isn't an official endpoint at this time.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.